FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway

Abstract Background Lung adenocarcinoma (LUAD) is highly malignant and associated with poor prognoses in patients worldwide. There has been widespread recognition that lncRNAs are tightly linked to LUAD tumorigenesis and development. Here, we identified that the LINC00621 level was increased in LUAD...

Full description

Bibliographic Details
Main Authors: Jingjing Wei, Haiyang Yu, Tan Liu, Ziming Wang, Chuandong Lang, Yueyin Pan
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14986
_version_ 1797773551107833856
author Jingjing Wei
Haiyang Yu
Tan Liu
Ziming Wang
Chuandong Lang
Yueyin Pan
author_facet Jingjing Wei
Haiyang Yu
Tan Liu
Ziming Wang
Chuandong Lang
Yueyin Pan
author_sort Jingjing Wei
collection DOAJ
description Abstract Background Lung adenocarcinoma (LUAD) is highly malignant and associated with poor prognoses in patients worldwide. There has been widespread recognition that lncRNAs are tightly linked to LUAD tumorigenesis and development. Here, we identified that the LINC00621 level was increased in LUAD tissues and concerned with the poor prognoses in LUAD patients. Methods Bioinformatical analysis and RT‐qPCR determined the level of LINC00621 in LUAD tissues and cell lines. The admeasurement of the proliferation, migration, and invasion abilities of LUAD cells was utilized in the CCK8 and Transwell formulas. Luciferase reporter assay was used to corroborate the downstream target genes of LINC00621. The phosphorylated SMAD3 protein was tested by Western blotting assay. The impression of LINC00621 knockdown on LUAD tumor growth and metastasis put into effect by murine models. ChIP‐qPCR assay was carried out to verify the transcriptional regulation by FOXA1 on LINC00621. Results In vitro, the knockdown of LINC00621 significantly reduced the proliferative, migrating, and invasive abilities, the same was true for tumorigenesis and metastasis in vivo. MiR‐34a‐5p as a straight target of LINC00621 was ascertained, and LUAD patients with inferior miR‐34a‐5p levels had undesirable prognoses. Furthermore, TGFBR1 is an immediate and functional connection site of miR‐34a‐5p. Collectively, LINC00621 can sponge miR‐34a‐5p and upregulate TGFBR1 levels, which further sensitized TGF‐β signaling pathway. Finally, it was revealed that FOXA1 transcriptionally upregulated LINC00621. Conclusion This study uncovered that FOXA1‐induced LINC00621 promotes LUAD progression via the miR‐34a‐5p/TGFBR1/TGF‐β axis, and is one novel therapeutic target that may be used in LUAD treatment.
first_indexed 2024-03-12T22:08:06Z
format Article
id doaj.art-7884129ee02d42c38f88d724a36fa9f7
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-03-12T22:08:06Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-7884129ee02d42c38f88d724a36fa9f72023-07-24T08:06:25ZengWileyThoracic Cancer1759-77061759-77142023-07-0114212026203710.1111/1759-7714.14986FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathwayJingjing Wei0Haiyang Yu1Tan Liu2Ziming Wang3Chuandong Lang4Yueyin Pan5Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaDepartment of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaDepartment of Medical Oncology 901 Hospital of Joint Logistics Support Force of People Liberation Army Hefei ChinaDepartment of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaDepartment of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaDepartment of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaAbstract Background Lung adenocarcinoma (LUAD) is highly malignant and associated with poor prognoses in patients worldwide. There has been widespread recognition that lncRNAs are tightly linked to LUAD tumorigenesis and development. Here, we identified that the LINC00621 level was increased in LUAD tissues and concerned with the poor prognoses in LUAD patients. Methods Bioinformatical analysis and RT‐qPCR determined the level of LINC00621 in LUAD tissues and cell lines. The admeasurement of the proliferation, migration, and invasion abilities of LUAD cells was utilized in the CCK8 and Transwell formulas. Luciferase reporter assay was used to corroborate the downstream target genes of LINC00621. The phosphorylated SMAD3 protein was tested by Western blotting assay. The impression of LINC00621 knockdown on LUAD tumor growth and metastasis put into effect by murine models. ChIP‐qPCR assay was carried out to verify the transcriptional regulation by FOXA1 on LINC00621. Results In vitro, the knockdown of LINC00621 significantly reduced the proliferative, migrating, and invasive abilities, the same was true for tumorigenesis and metastasis in vivo. MiR‐34a‐5p as a straight target of LINC00621 was ascertained, and LUAD patients with inferior miR‐34a‐5p levels had undesirable prognoses. Furthermore, TGFBR1 is an immediate and functional connection site of miR‐34a‐5p. Collectively, LINC00621 can sponge miR‐34a‐5p and upregulate TGFBR1 levels, which further sensitized TGF‐β signaling pathway. Finally, it was revealed that FOXA1 transcriptionally upregulated LINC00621. Conclusion This study uncovered that FOXA1‐induced LINC00621 promotes LUAD progression via the miR‐34a‐5p/TGFBR1/TGF‐β axis, and is one novel therapeutic target that may be used in LUAD treatment.https://doi.org/10.1111/1759-7714.14986FOXA1LINC00621lung adenocarcinomaMiR‐34a‐5pTGF‐β
spellingShingle Jingjing Wei
Haiyang Yu
Tan Liu
Ziming Wang
Chuandong Lang
Yueyin Pan
FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
Thoracic Cancer
FOXA1
LINC00621
lung adenocarcinoma
MiR‐34a‐5p
TGF‐β
title FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
title_full FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
title_fullStr FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
title_full_unstemmed FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
title_short FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
title_sort foxa1 induced linc00621 promotes lung adenocarcinoma progression via activating the tgf β signaling pathway
topic FOXA1
LINC00621
lung adenocarcinoma
MiR‐34a‐5p
TGF‐β
url https://doi.org/10.1111/1759-7714.14986
work_keys_str_mv AT jingjingwei foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway
AT haiyangyu foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway
AT tanliu foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway
AT zimingwang foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway
AT chuandonglang foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway
AT yueyinpan foxa1inducedlinc00621promoteslungadenocarcinomaprogressionviaactivatingthetgfbsignalingpathway